Bacterial Lysates Add‐On Therapy to Reduce Postoperative Recurrence in Nasal Polyps
The Laryngoscope · 2026
DOI: 10.1002/lary.70581 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Laryngoscope, 2026. Verfasst von Huiyi Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Nasal Polyps, Cell Extracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
This study aimed to investigate the potential role of OM‐85 in reducing polyp recurrence (PR).
Methods
A single‐center randomized, prospective study was performed to compare the inter‐group PR rate, patient‐reported outcome measures (PROMs), CT and endoscopic scores. Hundred patients were randomized to receive either add‐on OM‐85 (34/50) or control group (43/50); 77 participants completed the 12‐month follow‐up. The OM‐85 group received oral treatment for 10 days, followed by a 20‐day washout (Months 1–3 and 7–9). Primary outcome was the PR rate. Secondary outcomes included PROMs, Lund‐Kennedy (L‐K) scores, Lund‐Mackay (L‐M) scores, and complete blood count (CBC) parameters.
Results
The PR rate was significantly lower in the OM‐85 group (8.82%) than in the control group (27.91%, χ 2 = 4.408, p = 0.036). Univariable analysis identified pre‐operative Lund‐Mackay (L‐M) score ( p = 0.008) and hyposmia VAS score ( p = 0.031) as significant predictors of PR. In multivariable analysis, the L‐M score remained an independent predictor (OR = 1.15, p = 0.012), with an optimal cutoff of 10. The OM‐85 group showed significant improvements in nasal obstruction, olfactory dysfunction, and mucopurulent discharge at 6 and 12 months ( p < 0.05). Lund‐Kennedy (L‐K) score and 22‐item Sinonasal Outcome Test (SNOT‐22) score were also significantly improved ( p < 0.05). Furthermore, the OM‐85 group exhibited elevated white blood cell counts and lymphocyte percentages from 6 months onward ( p < 0.05).
Conclusion
Adjuvant OM‐85 may reduce postoperative PR, with improved endoscopic and symptom scores, potentially mediated by enhanced systemic immune function. Level of Evidence 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Huiyi Deng, Shuo Wu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Deng, H., Qiu, H., Yuan, T., Wu, S., & Yang, Q. (2026). Bacterial Lysates Add‐On Therapy to Reduce Postoperative Recurrence in Nasal Polyps. The Laryngoscope. https://doi.org/10.1002/lary.70581
Vancouver
Deng H, Qiu H, Yuan T, Wu S, Yang Q. Bacterial Lysates Add‐On Therapy to Reduce Postoperative Recurrence in Nasal Polyps. The Laryngoscope. 2026. doi:10.1002/lary.70581
BibTeX
@article{Deng2026,
author = {Deng, Huiyi and Qiu, Huijun and Yuan, Tian and Wu, Shuo and Yang, Qintai},
title = {Bacterial Lysates Add‐On Therapy to Reduce Postoperative Recurrence in Nasal Polyps},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.70581}
}
EUVIMED